Sector Gamma ASA
Latest statistics and disclosures from Sector Gamma As's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GILD, PFE, BMY, MDT, ELV, and represent 41.13% of Sector Gamma As's stock portfolio.
- Added to shares of these 6 stocks: GILD (+$11M), AMGN (+$9.4M), ABT (+$7.3M), BMY, CNC, BRKR.
- Started 2 new stock positions in ABT, AMGN.
- Reduced shares in these 10 stocks: MDT (-$12M), PFE (-$9.6M), CAH (-$7.4M), UHS (-$6.5M), GMED (-$5.7M), ELV (-$5.4M), CVS (-$5.2M), BIO, ZBH, INCY.
- Sold out of its positions in GMED, ILMN.
- Sector Gamma As was a net seller of stock by $-63M.
- Sector Gamma As has $268M in assets under management (AUM), dropping by -24.55%.
- Central Index Key (CIK): 0001475373
Tip: Access up to 7 years of quarterly data
Positions held by Sector Gamma ASA consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Sector Gamma As
Sector Gamma As holds 28 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Gilead Sciences (GILD) | 10.8 | $29M | +58% | 420k | 68.61 |
|
Pfizer (PFE) | 9.4 | $25M | -27% | 895k | 27.98 |
|
Bristol Myers Squibb (BMY) | 8.3 | $22M | +7% | 535k | 41.53 |
|
Medtronic SHS (MDT) | 7.8 | $21M | -35% | 265k | 78.71 |
|
Anthem (ELV) | 4.9 | $13M | -29% | 24k | 541.86 |
|
CVS Caremark Corporation (CVS) | 4.9 | $13M | -28% | 220k | 59.06 |
|
Incyte Corporation (INCY) | 4.6 | $12M | -23% | 203k | 60.62 |
|
Cardinal Health (CAH) | 3.9 | $11M | -41% | 107k | 98.32 |
|
Biogen Idec (BIIB) | 3.8 | $10M | -26% | 44k | 231.82 |
|
Amgen (AMGN) | 3.5 | $9.4M | NEW | 30k | 312.45 |
|
Zimmer Holdings (ZBH) | 3.4 | $9.2M | -29% | 85k | 108.53 |
|
Baxter International (BAX) | 3.2 | $8.7M | -19% | 260k | 33.45 |
|
Ge Healthcare Technologies I Common Stock (GEHC) | 3.0 | $8.1M | -15% | 104k | 77.92 |
|
Ionis Pharmaceuticals (IONS) | 3.0 | $8.1M | -3% | 170k | 47.66 |
|
Bruker Corporation (BRKR) | 2.8 | $7.4M | +2% | 116k | 63.81 |
|
Abbott Laboratories (ABT) | 2.7 | $7.3M | NEW | 70k | 103.91 |
|
Tenet Healthcare Corp Com New (THC) | 2.6 | $7.0M | -31% | 53k | 133.03 |
|
Universal Hlth Svcs CL B (UHS) | 2.4 | $6.5M | -49% | 35k | 184.93 |
|
Edwards Lifesciences (EW) | 2.4 | $6.4M | -35% | 69k | 92.37 |
|
Agios Pharmaceuticals (AGIO) | 2.0 | $5.3M | -25% | 122k | 43.12 |
|
BioMarin Pharmaceutical (BMRN) | 1.9 | $5.2M | -22% | 63k | 82.33 |
|
Alkermes SHS (ALKS) | 1.7 | $4.7M | -23% | 194k | 24.10 |
|
Bio Rad Labs Cl A (BIO) | 1.7 | $4.6M | -50% | 17k | 273.11 |
|
Alnylam Pharmaceuticals (ALNY) | 1.4 | $3.7M | -44% | 15k | 243.00 |
|
Qiagen Nv Shs New (QGEN) | 1.3 | $3.4M | -19% | 84k | 41.09 |
|
Centene Corporation (CNC) | 1.1 | $3.0M | +102% | 45k | 66.30 |
|
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.0 | $2.5M | -40% | 32k | 80.29 |
|
Viatris (VTRS) | 0.4 | $1.1M | -75% | 103k | 10.63 |
|
Past Filings by Sector Gamma As
SEC 13F filings are viewable for Sector Gamma As going back to 2010
- Sector Gamma As 2024 Q2 filed Aug. 9, 2024
- Sector Gamma As 2024 Q1 filed May 8, 2024
- Sector Gamma As 2023 Q4 filed Feb. 5, 2024
- Sector Gamma As 2023 Q3 filed Nov. 6, 2023
- Sector Gamma As 2023 Q2 filed Aug. 9, 2023
- Sector Gamma As 2023 Q1 filed May 12, 2023
- Sector Gamma As 2022 Q4 restated filed Feb. 8, 2023
- Sector Gamma As 2022 Q4 filed Feb. 7, 2023
- Sector Gamma As 2022 Q3 filed Nov. 9, 2022
- Sector Gamma As 2022 Q2 filed Aug. 5, 2022
- Sector Gamma As 2022 Q1 filed May 6, 2022
- Sector Gamma As 2021 Q4 filed Feb. 8, 2022
- Sector Gamma As 2021 Q3 filed Oct. 29, 2021
- Sector Gamma As 2021 Q2 filed Aug. 4, 2021
- Sector Gamma As 2021 Q1 filed May 10, 2021
- Sector Gamma As 2020 Q4 filed Feb. 10, 2021